**[미래에셋 제약/바이오 김승민]**
**11/13 Daily**

[https://t.me/bioksm](https://t.me/bioksm)


 **글로벌 바이오/제약**
────────────────────
 [Lilly, GLP-1 체중 감량 경구제 중국 첫 승인](https://news.google.com/rss/articles/CBMixgFBVV95cUxPOUU5ZDQ0R21WMzVHcEo1TmhfNG5BWGR0Ukk4Y3hLQTZHa0JfUGRjOFlneUcxNEt2SXZHYk9SOXZFWW1OWXFUVVFDTDZNLTI5TnVpS0VyalRvTm0xXzFGcXNGWkhNVXlrOHFnRFJVcjFpS2Z4N3FVejNHWURTSjgzN0dWUFFfWW1ZWHVTU0prel9yUlRuY1hRSmRqZnhrbmZBb3BQRUVXNHlXSEg2dlR5bnZGa1FmTGFEalFQMEtyVkJfQ2JCenc?oc=5)

 [Pfizer, 월간 GLP-1 개발 자금 조달을 위해 블랙스톤과 최대 15억 달러 제휴](https://news.google.com/rss/articles/CBMiU0FVX3lxTE0yX0I0NFFDTnFWVkF6aG96Z2VkeVp6akxfS3JjLW93dUo1bWpSRXhrSWR4clBRdWRnRS0tMWhCdURHLTJYTms2YjZFVkZhbDlmMFVv?oc=5)

 [BMS R&D 책임자, 구조 조정 속 퇴임](https://news.google.com/rss/articles/CBMifkFVX3lxTE5ReHJVRnU1Z25PQ0lSd1R0X19raGQyRWxyOHp4RXBjZlBtaEhPTUVfcXdwWFR6YTBCdjBud3FTRm5BejA0NlBjOTlielFxdnF4QkJYU1lUbUFlV1k1SVFfblBCa05DM1VJMHlTaURnX3hsZ2FQaERUYWpCTEdZdw?oc=5)

 [Takeda, DEA 승인 후 미국에서 수면장애 치료제 출시](https://news.google.com/rss/articles/CBMi5gFBVV95cUxOZnlDQWRTN1ZJckhRZEU5ak5xQU5CcUJ4b3c5V1FPaWo1YWRTcS1kTTM1RERfRTFneWVGcG9HbXQ0dDJyZGdTSlp5eTEtUl9HN2MzZWdaTERXZ2djQ2pCQlNlTkVpZG5uUXYydnVWT0t5XzlrSHFjTzJOM0FLRlBDQzcwQ3kzeTdmWGZ6cFFWaTF2aUgzWmRrNWpVbDMtSHYxbEotT180VU82dEk0emxlRzk5MzNjem1TVmNNYktJOXNjbll0ZDI4YzRjQTl3M044OG96cUJpMDZvMVVwTnFlX2Jvb1NoZw?oc=5)

 [FDA 승인 타겟 일정 줄줄이... 11월 말~연말 바이오텍 달력 채워](https://news.google.com/rss/articles/CBMi1gFBVV95cUxPOTg0OEdjR2Z0akZNMVdyOWE4MkFEN0ZlSEpwekwzTExDaUxCUWNkY2dHQTM0cE84enhMSVpiTGlnOVdYcWdjcTRFRzcyTUpnMl9PQUFxa01nNlJNRnRFdXpXYUpLcnAxWTlGTTNyODgxdTc5SkhYUHRkWmM0R0pTNDVObFpvUUxwaVo2cmotTlpyUkl0eTFHUlpKQkplY0VYZ3hIR1R1Sl9GT2xvbXcyc1VKb3JwRUR0ZWQ3amxtZnhFc2F3cjZwdDdsYlNwNW9tUTN3a2VR?oc=5)

 [Google Gemini가 의료AI시장에 진출](https://endpoints.news/gemini-getting-in-the-health-ai-game/)

 [미국 FDA, 신약 신속 검토용 커미셔너 바우처 프로그램 잠정 중단](https://news.google.com/rss/articles/CBMiugFBVV95cUxORWpkVElUa0dxMUx5dlJuNjBCTGI4ZVRRT0xkTDRpUl9zOVFJYzZfZ1JnaUREb2VacDlLUlBDWlVQdlhmY09hNzV2M2t1Z2Foc0xRSXpDUGdYcVlteEhBTEtGVlAzZno5WGNmWjQzZlIzSG1VcDNHU2U4N1p0UHZfM3VjYzBnWE9RV003TkFfUGthRUxBWUxtMndIQ0dsT2VmcnQ2ckxUbnpVZlV6U3VnSDBxTlpBU044Unc?oc=5)


 **한국 바이오/제약**
────────────────────
 [셀트리온 ‘코센틱스’ 바이오시밀러 ‘비세큐마’ 호주 품목허가 신청](https://news.google.com/rss/articles/CBMibkFVX3lxTE0tVFlLNVNUdXBGbTUyRlE1VVhyNGhwN043a3M2TzFZYkZQclNybklHd2VWSTJwWS1nQk40MU53eUt2b0hVNWtGV3VfcmZKbEpaMjhGTWYzcUZFVVJMeHZ0cWJWc0JQTDJ4YWp5ZFBR?oc=5)

 [삼성바이오에피스, 지주회사에 1043억원 현금배당](https://www.hitnews.co.kr/news/articleView.html?idxno=80730)

 [디앤디파마텍, 미 관계사에 100억 추가 출자](https://www.hitnews.co.kr/news/articleView.html?idxno=80720)

 [대웅제약, 장 점막 재생 겨냥한 신약 임상 1상 돌입](https://www.hitnews.co.kr/news/articleView.html?idxno=80715)

 [일동제약 바이오 유럽 참가, P-CAB ‘파도프라잔’ 상업화에 속도](https://news.google.com/rss/articles/CBMiWkFVX3lxTE95Zzh3STJ3MjJsX2FQcElONWllV0FyMW9fbGVyOWl1NU1BM1FkcTR2eFJqZjA0djlRSDJXNnlTTVNuakYyaXQ1XzdNR1dIbWV3ZldoUVlidkZEZw?oc=5)